Cargando…

Aberrant insulin signaling in Alzheimer's disease: current knowledge

Alzheimer's disease (AD) is the most common form of dementia affecting elderly people. AD is a multifaceted pathology characterized by accumulation of extracellular neuritic plaques, intracellular neurofibrillary tangles (NFTs) and neuronal loss mainly in the cortex and hippocampus. AD etiology...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bedse, Gaurav, Di Domenico, Fabio, Serviddio, Gaetano, Cassano, Tommaso
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2015
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4468388/ https://www.ncbi.nlm.nih.gov/pubmed/26136647 http://dx.doi.org/10.3389/fnins.2015.00204

Ejemplares similares

Depressive-Like Behavior Is Paired to Monoaminergic Alteration in a Murine Model of Alzheimer’s Disease
por: Romano, Adele, et al.
Publicado: (2015)

From Cannabis sativa to Cannabidiol: Promising Therapeutic Candidate for the Treatment of Neurodegenerative Diseases
por: Cassano, Tommaso, et al.
Publicado: (2020)

Pharmacological Treatment of Depression in Alzheimer’s Disease: A Challenging Task
por: Cassano, Tommaso, et al.
Publicado: (2019)

Astrocyte Function Is Affected by Aging and Not Alzheimer’s Disease: A Preliminary Investigation in Hippocampi of 3xTg-AD Mice
por: Bronzuoli, Maria Rosanna, et al.
Publicado: (2019)

The Glucose Metabolic Pathway as A Potential Target for Therapeutics: Crucial Role of Glycosylation in Alzheimer’s Disease
por: Bukke, Vidyasagar Naik, et al.
Publicado: (2020)

The Dual Role of Glutamatergic Neurotransmission in Alzheimer’s Disease: From Pathophysiology to Pharmacotherapy
por: Bukke, Vidyasagar Naik, et al.
Publicado: (2020)

Autoimmune liver disease and multiple sclerosis: state of the art and future perspectives
por: Villani, Rosanna, et al.
Publicado: (2023)

Berberine Ameliorates Diabetes-Associated Cognitive Decline through Modulation of Aberrant Inflammation Response and Insulin Signaling Pathway in DM Rats
por: Chen, Qingjie, et al.
Publicado: (2017)

Pharmacological and Toxicological Effects of Phytocannabinoids and Recreational Synthetic Cannabinoids: Increasing Risk of Public Health
por: Bukke, Vidyasagar Naik, et al.
Publicado: (2021)

Biological mechanisms associated with increased perseveration and hyperactivity in a genetic mouse model of neurodevelopmental disorder
por: Trent, Simon, et al.
Publicado: (2013)

Metabolic reprogramming in inflammatory microglia indicates a potential way of targeting inflammation in Alzheimer's disease
por: Sangineto, Moris, et al.
Publicado: (2023)

Risk Factors for Alzheimer’s Disease: Focus on Stress
por: Caruso, Alessandra, et al.
Publicado: (2019)

Alterations of Clock Gene RNA Expression in Brain Regions of a Triple Transgenic Model of Alzheimer’s Disease
por: Bellanti, Francesco, et al.
Publicado: (2017)

Revisiting the neuroinflammation hypothesis in Alzheimer’s disease: a focus on the druggability of current targets
por: Wong-Guerra, Maylin, et al.
Publicado: (2023)

Knowledge on Alzheimer's Disease among Public Hospitals and Health Clinics Pharmacists in the State of Selangor, Malaysia
por: Mat Nuri, Thimarul Huda, et al.
Publicado: (2017)

Tirzepatide ameliorates spatial learning and memory impairment through modulation of aberrant insulin resistance and inflammation response in diabetic rats
por: Guo, Xiying, et al.
Publicado: (2023)

Effects of Ultramicronized Palmitoylethanolamide on Mitochondrial Bioenergetics, Cerebral Metabolism, and Glutamatergic Transmission: An Integrated Approach in a Triple Transgenic Mouse Model of Alzheimer's Disease
por: Bellanti, Francesco, et al.
Publicado: (2022)

Impact of Alzheimer’s disease and related dementias on colorectal cancer screening utilization, knowledge, and associated health disparities
por: Lv, Gang, et al.
Publicado: (2022)

Insulin-induced mTOR signaling and gluconeogenesis in renal proximal tubules: A mini-review of current evidence and therapeutic potential
por: Nakamura, Motonobu, et al.
Publicado: (2022)

Enhancement of Insulin/PI3K/Akt Signaling Pathway and Modulation of Gut Microbiome by Probiotics Fermentation Technology, a Kefir Grain Product, in Sporadic Alzheimer’s Disease Model in Mice
por: El Sayed, Nesrine S., et al.
Publicado: (2021)

Prevalence and risk factors for hospital-acquired anemia in internal medicine patients: learning from the “less is more” perspective
por: Villani, Rosanna, et al.
Publicado: (2022)

Current Insights on the Use of Insulin and the Potential Use of Insulin Mimetics in Targeting Insulin Signalling in Alzheimer’s Disease
por: Woodfield, Amy, et al.
Publicado: (2022)

Importance of Increasing Modifiable Risk Factors Knowledge on Alzheimer’s Disease Among Community Pharmacists and General Practitioners in Spain
por: Alacreu, Mónica, et al.
Publicado: (2019)

Brain Insulin Signaling and Alzheimer's Disease: Current Evidence and Future Directions
por: Schiöth, Helgi B., et al.
Publicado: (2011)

The Use of Antipsychotic Drugs for Treating Behavioral Symptoms in Alzheimer’s Disease
por: Calsolaro, Valeria, et al.
Publicado: (2019)

DNA Methylation Aberrant in Atherosclerosis
por: Dai, Yao, et al.
Publicado: (2022)

The Hyperactivity–Impulsivity–Irritiability–Disinhibition–Aggression–Agitation Domain in Alzheimer’s Disease: Current Management and Future Directions
por: Keszycki, Rachel M., et al.
Publicado: (2019)

Modeling Alzheimer’s disease: from past to future
por: Saraceno, Claudia, et al.
Publicado: (2013)

Current knowledge of leptin in wound healing: A collaborative review
por: Yuan, Chi, et al.
Publicado: (2022)

Peripheral Dopamine Directly Acts on Insulin-Sensitive Tissues to Regulate Insulin Signaling and Metabolic Function
por: Tavares, Gabriela, et al.
Publicado: (2021)

Ultramicronized palmitoylethanolamide rescues learning and memory impairments in a triple transgenic mouse model of Alzheimer’s disease by exerting anti-inflammatory and neuroprotective effects
por: Scuderi, Caterina, et al.
Publicado: (2018)

Insulin-Like Growth Factor Binding Proteins in Kidney Disease
por: Wang, Shuqiang, et al.
Publicado: (2021)

Adenosine and Kynurenic Acid Interactions: Possible Relevance for Schizophrenia Treatment?
por: Beggiato, Sarah, et al.
Publicado: (2021)

Hepatoprotective agents in the management of intrahepatic cholestasis of pregnancy: current knowledge and prospects
por: Shan, Dan, et al.
Publicado: (2023)

c-Jun N-terminal Kinase (JNK) Signaling as a Therapeutic Target for Alzheimer’s Disease
por: Yarza, Ramon, et al.
Publicado: (2016)

Genetic Polymorphisms and Clinical Features in Diabetic Patients With Fatty Liver: Results From a Single-Center Experience in Southern Italy
por: Villani, Rosanna, et al.
Publicado: (2021)

Current Naturopathy to Combat Alzheimer’s Disease
por: Chakrovorty, Arnob, et al.
Publicado: (2023)

Aberrant ROS Mediate Cell Cycle and Motility in Colorectal Cancer Cells Through an Oncogenic CXCL14 Signaling Pathway
por: Zeng, Jun, et al.
Publicado: (2021)

Microglia Function in Alzheimer’s Disease
por: Solito, Egle, et al.
Publicado: (2012)

Consequences of Aberrant Insulin Regulation in the Brain: Can Treating Diabetes be Effective for Alzheimer’s Disease
por: Arab, L, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_5ckjbu9o3thdudup74nt9m3n0m